FDA approves new Alzheimer's treatment from Eli Lilly
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.